Patients with inflammatory bowel disease (IBD) often carry another risk SNP, the rs2836754 allele (T), which leads to disease-specific ETS2-SE activation both in IBD and CRC since TF MECOM prefers binding at the T allele over C in this region. Here, ETS2 is linked to colorectal carcinoma.